Scientific Opinion on the developmental neurotoxicity potential of acetamiprid and imidacloprid

EFSA Journal

Volumn 11, Issue 12, 2013, Pages

  Bennekou, Susanne Hougaard ^a  

^a NONE

Author keywords

developmental neurotoxicity risk assessment; in vitro testing; nAChR agonists; neonicotinoid; pesticide approval regulations

Indexed keywords

EID: 85020073858     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2013.3471     Document Type: Article

References (109)

1. Abou-Donia MB, Goldstein LB, Bullman S, Tu T, Khan WA, Dechkovskaia AM and Abdel-Rahman AA, 2008. Imidacloprid induces neurobehavioral deficits and increases expression of glial fibrillary acidic protein in the motor cortex and hippocampus in offspring rats following in utero exposure. J Toxicol Environ Health A, 71, 119–130
2. Agulhon C, Charnay Y, Vallet P, Abitbol M, Kobetz A, Bertrand D and Malafosse A, 1998. Distribution of mRNA for the alpha4 subunit of the nicotinic acetylcholine receptor in the human fetal brain. Brain Res Mol Brain Res, 58, 123–131
3. Albuquerque EX, Pereira EF, Alkondon M and Rogers SW, 2009. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev, 89, 73–120
4. Altman J and Bayer SA, 1985. Embryonic development of the rat cerebellum. III. Regional differences in the time of origin, migration, and settling of Purkinje cells. J Comp Neurol, 231, 42–65
5. + antiporter that interacts with addictive drugs. Journal of Cerebral Blood Flow & Metabolism, 29, 1293–1304
6. Arena J, 1974. Poisoning. IV ed. Thomas C (ed), New York
7. Azevedo FA, Carvalho LR, Grinberg LT, Farfel JM, Ferretti RE, Leite RE, Jacob Filho W, Lent R and Herculano-Houzel S, 2009. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol. 10;513(5):532–41
8. Bal R, Erdogan S, Theophilidis G, Baydas G and Naziroglu M, 2010. Assessing the effects of the neonicotinoid insecticide imidacloprid in the cholinergic synapses of the stellate cells of the mouse cochlear nucleus using whole-cell patch-clamp recording. Neurotoxicology, 31, 113–120
9. Bal-Price AK, Hogberg HT, Buzanska L and Coecke S, 2010a. Relevance of in vitro neurotoxicity testing for regulatory requirements: Challenges to be considered. Neurotoxicology Teratol, 32, 36–41
10. Bal-Price AK, Hogberg HT, Buzanska L, Lenas P, van Vliet E and Hartung T, 2010b In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints. Neurotoxicology, 31, 545–554
11. Bal-Price AK, Coecke S, Costa L, Crofton KM, Fritsche E, Goldberg A, Grandjean P, Lein PJ, Li A, Lucchini R, Mundy WR, Padilla S, Persico AM, Seiler AE and Kreysa J, 2012. Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. ALTEX, 29, 202–215
12. Ballabh P, Braun A and Nedergaard M, 2004. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis, 16, 1–13
13. Benowitz NL, Porchet H, Scheiner L and Jacob P III, 1988. Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clin Pharmacol Ther, 44, 23–28
14. Beronius A, Hanberg A, Heimeier R and Håkansson H, 2013. Risk assessment of DNT. Evaluation of the OECD TG 426 test guideline and guidance documents. Karolinska Institute. IMM rapport 1/2013
15. Biran V, Verney C and Ferriero DM, 2012. Perinatal cerebellar injury in human and animal models. Neurol Res Int, 10.1155/2012/858929
16. California Environmental Protection Agency, 2006. Imidacloprid. Risk characterisation document dietary and drinking water exposure. February 9, 2006. Available online: www.cdpr.ca.gov/docs/risk/rcd/imidacloprid.pdf
17. Campbell NR, Fernandes CC and Halff AW, Berg DK, 2010. Endogenous signalling through alpha7-containing nicotinic receptors promotes maturation and integration of adult-born neurons in the hippocampus. J Neurosci, 30, 8734–8744
18. Chao SL and Casida JE, 1997. Interaction of imidacloprid metabolites and analogs with the nicotinic acetylcholine receptor of mouse brain in relation to toxicity. Pestic Biochem Physiol, 58, 77–78
19. Cisternino S, Chapy H, André P, Smirnova M, Debray M and Scherrmann JM, 2013. Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier. AAPS J, 15, 299–307
20. Court JA, Lloyd S, Johnson M, Griffiths M, Birdsall NJ, Piggott MA, Oakley AE, Ince PG, Perry EK and Perry RH, 1997. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Dev Brain Res, 101, 93–105
21. Court JA, Martin-Ruis C, Graham A and Perry E, 2000. Nicotinic receptors in human brain: topography and pathology. J Chem Neuroanat, 20, 281–298
22. Courjaret R and Lapied B, 2001. Complex intracellular messenger pathways regulate one type of neuronal alpha-bungarotoxin-resistant nicotinic acetylcholine receptors expressed in insect neurosecretory cells (dorsal unpaired median neurons). Mol Pharmacol, 60, 80–91
23. Dani JA, 2001. Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry, 49, 166–174
24. de Oliveira IM, Nunes BV, Barbosa DR, Pallares AM and Faro LR, 2010. Effects of the neonicotinoids thiametoxam and clothianidin on in vivo dopamine release in rat striatum. Toxicol Lett, 192, 294–297
25. Dick RA, Kanne DB and Casida JE, 2007. Nitroso-imidacloprid irreversibly inhibits rabbit aldehyde oxidase. Chem Res Toxicol, 20, 1942–1946
26. Dwyer JB, McQuown SC and Leslie FM, 2009. The dynamic effects of nicotine on the developing brain. Pharmacol Ther, 122, 125–139
27. EFSA (European Food Safety Authority), 2008. Conclusion regarding the peer review of the pesticide risk assessment of imidacloprid. The EFSA Journal, 148r, 1–120
28. Engelhardt B, 2006. Regulation of immune cell entry into the central nervous system. Results Probl Cell Differ, 43, 259–280
29. Engelhardt B, 2008. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des, 14, 1555–1565
30. Falk L, Nordberg A, Seiger A, Kjaeldgaard A and Hellström-Lindahl E, 2002. The alpha7 nicotinic receptors in human fetal brain and spinal cord. J Neurochem, 80, 457–465
31. Farrant M, Feldmeyer D, Takahashi T and Cull-Candy SG, 1994. NMDA-receptor channel diversity in the developing cerebellum. Nature, 368, 335–339
32. Ford KA and Casida JE, 2006. Chloropyridinylneonicotinoid insecticides: diverse molecular substituents contribute to facile metabolism in mice. Chem Res Toxicol, 19, 944–951
33. Gallo V, Kingsbury A, Balázs R and Jørgensen OS, 1987. The role of depolarisation in the survival and differentiation of cerebellar granule cells in culture. J Neurosci, 7, 2203–2213
34. Germany, 2005. Draft assessment report on the active substance imidacloprid prepared by the rapporteur Member State Germany in the framework of Directive 91/414/EEC, December 2005.
35. Gervais JA, Luukinen B, Buhl K and Stone D, 2010. Imidacloprid Technical Fact Sheet; National Pesticide Information Center, Oregon State University Extension Services. npic.orst.edu/factsheets/imidacloprid.pdf
36. Gosselin RE, 1988. Clinical toxicology of Commercial Products. 6th ed, Baltimore, Williams & Wilkins, pp 311–313
37. Giser IR, Ficks C and Waldman ID, 2009. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet, 126, 51–90
38. Greece, 2000. Draft assessment report on the active substance acetamiprid prepared by the rapporteur Member State Greece in the framework of Directive 91/414/EEC, March 2001.
39. Hatton GI, 2002. Glial-neuronal interactions in the mammalian brain. Adv Physiol Educ, 26, 225–237
40. Hohmann CF and Berger-Sweeney J, 1998. Cholinergic regulation of cortical development and plasticity. New twists to an old story. Perspect Dev Neurobiol, 5, 401–225
41. Hogberg HT, Kinsner-Ovaskainen A, Coecke S, Hartung T and Bal-Price AK, 2010. mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol Sci, 113, 95–115
42. Ihara M, Matsuda K, Shimomura M, Sattelle DB and Komai K, 2004. Super agonist actions of clothianidin and related compounds on the SAD b2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Biosci Biotechnol Biochem, 68, 761–763
43. Imamura T, Yanagawa Y, Nishikawa K, Matsumoto N and Sakamoto T, 2010. Two cases of acute poisoning with acetamiprid in humans. Clin Toxicol (Phila), 48, 851–853
44. JMPR report, 2005. Acetamiprid (246). FAO 2005, pp 23–44. Available online: www.fao.org/fileadmin/templates/agphome/documents/Pests_Pesticides/JMPR/Report11/Acetamiprid.pdf)
45. Kaufmann W, 2003. Current status of developmental neurotoxicity: an industry perspective. Toxicol Lett, 140, 161–169
46. Kimura-Kuroda J, Nagata I, Negishi-Kato M and Kuroda Y, 2002. Thyroid hormone-dependent development of mouse cerebellar Purkinje cells in vitro. Brain Res Dev Brain Res, 137, 55–65
47. Kimura-Kuroda J, Komuta Y, Kuroda Y, Hayashi M and Kawano H, 2012. Nicotine-like effects of the neonicotinoid insecticides acetamiprid and imidacloprid on cerebellar neurons from neonatal rats. PLoS One 2012; 7(2): e32432
48. Kousik SM, Napier TC and Carvey PM, 2012. The Effects of Psychostimulant Drugs on Blood Brain Barrier Function and Neuroinflammation. Front Pharmacol, 3, 121
49. Klein O, 1982. [14C]-NTN 33893: Biokinetic part of the “General metabolism study” in the rat according to the “EPA pesticide assessment guidelines, subdivision F”, EPA 54019-82-025. November 1982, including the tissue distribution study to suit the Japanese requirements. Bayer AG, unpublished report No. 2889, date: 9.11-1987
50. Kramer D, Fresu L, Ashby DS, Freeman TC and Genazzani AA, 2003. Calcineurin controls the expression of numerous genes in cerebellar granule cells. Mol Cell Neurosci, 23, 325–330
51. Kurosaki M, Demontis S, Barzago MM, Garattini E and Terao M, 1999. Molecular cloning of the cDNA coding for mouse aldehyde oxidase: tissue distribution and regulation in vivo by testosterone. Biochem J, 341 (Pt 1), 71–80
52. Laudenbach V, Medja F, Zoli M, Rossi FM, Evrard P, Changeux JP and Gressens P, 2002. Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries. FASEB J, 16, 423–425
53. Li P, Ann J and Akk G, 2011. Activation and modulation of human α4β2 nicotinic acetylcholine receptors by the neonicotinoids clothianidin and imidacloprid. J Neurosci Res, 89, 1295–1301
54. Liebner S, Czupalla CJ and Wolburg H, 2011. Current concepts of blood-brain barrier development. Int J Dev Biol, 55, 467–476
55. Loeser JD, Lemire RJ and Alvord EC Jr, 1972. The development of the folia in the human cerebellar vermis. Anat Rec, 173, 109–113
56. Loy R and Sheldon AR, 1987. Sexually dimorphic development of cholinergic enzymes in the rat septohippocampal system. Dev Brain Res, 34, 156–160
57. Luck W and Nau H, 1984. Nicotine and cotinine concentrations in serum and milk of nursing smokers. Br J Clin Pharmacol, 18, 9–15
58. Luck W, Nau H, Hansen R and Steldinger R, 1985. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther, 8, 384–395
59. Mao C, Lv J, Li H, Chen Y, Wu J and Xu Z, 2007. Development of fetal nicotine and muscarinic receptors in utero. Cholinergic receptor development. Braz J Med Biol Res 2007; 40: 735–741
60. A receptor structure and physiological properties in cultured cerebellar granule neurons. Neuron, 13, 149–158
61. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM and Zirger JM, 2007. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl), 190, 269–319
62. Mellor JR, Merlo D, Jones A, Wisden W and Randall AD, 1998. Mouse cerebellar granule cell differentiation: Electrical activity regulates the GABAA receptor α6 subunit gene. J Neurosci, 18, 2822–2833
63. Mohamed F, Gawarammana I, Robertson TA, Roberts MS, Palangasinghe C, Zawahir S, Jayamanne S, Kandasamy J, Eddleston M, Buckley NA, Dawson AH and Roberts DM, 2009. Acute human self-poisoning with imidacloprid compound: a neonicotinoids insecticide. PLoS One 2009; 4(4): e5127.
64. Nagata K, Song JH, Shono T and Narahashi T, 1998. Modulation of the neuronal nicotinic acetylcholine receptor-channel by the nitromethylene heterocycle imidacloprid. J Pharmacol Exp Ther, 285, 731–738
65. Nagumo Y, Takeuchi Y, Imoto K and Miyata M, 2011. Synapse- and subtype-specific modulation of synaptic transmission by nicotinic acetylcholine receptors in the ventrobasal thalamus. Neurosci Res, 69, 203–213
66. 2+ signalling in development and maturation of mammalian cerebellar granule cells. J Physiol, 575, 389–395
67. Nishiwaki H, Nakagawa Y, Kuwamura M, Sato K, Akamatsu M, Matsuda K, Komai K and Miyagawa H, 2003. Correlations of the electrophysiological activity of neonicotinoids with their binding and insecticidal activities. Pest Manag Sci, 59, 1023–1030
68. OECD (Organisation for the Economic and Cooperation Development) Draft document. Retrospective performance of the test guideline 426 on developmental neurotoxicity. Available online: www.oecd.org/dataoecd/57/7/39824463.doc)
69. OECD, 2007. Test Guideline 426. OECD Guideline for testing of Chemicals. Developmental Neurotoxicity Study, 2007. Available online: www.oecd.org/document/55/0,3343,en_2649_34377_2349687_1_1_1_1,00.html
70. Okamoto M, Kita T, Okuda H, Tanaka T and Nakashima T, 1994. Effects of aging on acute toxicity of nicotine in rats. Pharmacol Toxicol, 75, 1–6
71. Olofsson PS, Katz DA, Rosas-Ballina M, Levine YA, Ochani M, Valdés-Ferrer SI, Pavlov VA, Tracey KJ and Chavan SS, 2012. α7 nicotinic acetylcholine receptor (α7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex. Mol Med, 18, 539–543
72. Patterson F, Benowitz N, Shields P, Kaufman V, Jepson C, Wileyto P, Kucharski S and Lerman C, 2003. Individual differences in nicotine intake per cigarette. Cancer Epidemiology Biomarkers Prev, 12, 468–471
73. Raffaele KC, Rowland J, May B, Makris SL, Schumacher K and Scarano LJ, 2010. The use of developmental neurotoxicity data in pesticide risk assessments. Neurotoxicol Teratol, 32, 563–572
74. Role LW and Berg DK, 1996. Nicotinic receptors in the development and modulation of CNS synapses. Neuron, 16, 1077–1085
75. Rose PH, 2012. Nicotine and neonicotinoids. In: Mammalian toxicology of insecticides (Marrs TC, ed.). The Royal Society of Chemistry, 2012, pp. 184–220
76. Rousseau SJ, Jones IW, Pullar IA and Wonnacott S, 2005. Presynaptic alpha7 andnon-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro. Neuropharmacology, 49: 59–72
77. Sastry BV, Chance MB, Singh G, Horn JL and Janson VE, 1995. Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time. Pharmacology, 50: 128–136
78. Sato M, Suzuki K, Yamazaki H and Nakanishi S, 2005. A pivotal role of calcineurin signaling in development and maturation of postnatal cerebellar granule cells. Proc Natl Acad Sci USA, 102: 5874–5879
79. Saunders NR, Habgood MD and Dziegielewska KM, 1999. Barrier mechanisms in the brain, II. Immature brain. ClinExpPharmacol Physiol, 26: 85–91
80. Sée V, Boutillier AL, Bito H and Loeffler JP, 2001. Calcium/calmodulin-dependent protein kinase type IV (CaMKIV) inhibits apoptosis induced by potassium deprivation in cerebellar granule neurons. FASEB J, 15: 134–144
81. Sher E, Chen Y, Sharples TJ, Broad LM, Benedetti G, Zwart R, McPhie GI, Pearson KH, Baldwinson T and De Filippi G, 2004. Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity. Curr Top Med Chem, 4: 283–297
82. Sidman RL and Rakic P, 1973. Neuronal migration, with special reference to developing human brain: a review. Brain Res, 62: 1–35
83. Singh TB, Mukhopadhayay SK, Sar TK and Ganguly S, 2012. Induced acetamiprid toxicity in mice: a review. J Drug Metab Toxicol 3: e115. doi:10.4172/2157-7609.1000e115
84. Slotkin TA, 1998. Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther, 285: 931–945
85. Suzuki K, Sato M, Morishima Y and Nakanishi S, 2005. Neuronal depolarisation controls brain-derived neurotrophic factor-induced upregulation of NR2C NMDA receptor via calcineurin signaling. J Neurosci, 25: 9535–9543
86. Swenson RS, 2006. Review of clinical and functional neuroscience. Motor system - The cerebellum (Chapter 8B). Online version developed at Dartmouth Medical School. Available online: www.dartmouth.edu/~rswenson/NeuroSci/chapter_8.html
87. Swenson TL and Casida JE, 2013. Aldehyde oxidase Importance in vivo in xenobiotic metabolism: Imidacloprid nitroreduction in mice. Toxicol Sci, 133: 22–28
88. Taly A and Charon S, 2012. Alpha7 nicotinic acetylcholine receptors: a therapeutic target in the structure era. Curr Drug Targets, 13: 695–706
89. Takarada T, Nakamichi N, Kitajima S, Fukumori R, Nakazato R, Le NQ, Kim YH, Fujikawa K, Kou M and Yoneda Y, 2012. Promoted neuronal differentiation after activation of alpha4/beta2 nicotinic acetylcholine receptors in undifferentiated neural progenitors. PLoS ONE 2012; 7(10): e46177
90. Tega Y, Akanuma S, Kubo Y, Terasaki T and Hosoya K, 2013. Blood-to-brain influx transport of nicotine at the rat blood-brain barrier: involvement of a pyrilamine-sensitive organic cation transport process. Neurochem Int, 62, 173–181.
91. Todani M, Kaneko T, Hayashida H, Kaneda K, Tsuruta R, Kasaoka S and Maekawa T, 2008. Acute poisoning with neonicotinoid insecticide acetamiprid. Chudoku Kenkyu, 21, 387–390.
92. Tomizawa M and Casida JE, 1999. Minor structural changes in nicotinoid insecticides confer differential subtype selectivity for mammalian nicotinic acetylcholine receptors. Br J Pharmacol, 127, 115–122.
93. Tomizawa M and Casida JE, 2000. Imidacloprid, thiacloprid, and their imine derivatives up-regulate the alpha 4 beta 2 nicotinic acetylcholine receptor in M10 cells. Toxicol Appl Pharmacol, 169, 114–120.
94. Tomizawa M and Casida JE, 2002. Desnitro-imidacloprid activates the extracellular signal-regulated kinase cascade via the nicotinic receptor and intracellular calcium mobilisation in N1E-115 cells. Toxicol Appl Pharmacol, 184, 180–186.
95. Tomizawa M and Casida JE, 2003. Selective toxicity of neonicotinoids attributable to specificity of insect and mammalian nicotinic receptors. Annu Rev Entomol, 48, 339–364.
96. Tribollet E, Bertrand D, Marguerat A and Raggenbass M, 2004. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience, 124, 405–420.
97. Tyl RW, Crofton K, Moretto A, Moser V, Sheets LP and Sobotka TJ, 2008. Identification and interpretation of developmental neurotoxicity effects: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol, 30, 349–381.
98. USDA Forest Service, 2005. Imidacloprid - Human Health and Ecological Risk Assessment - Final report. Prepared for USDA, Forest Service, Forest Health Protection, USA (SERA TR 05-43-24-03). Available online: www.fs.fed.us/foresthealth/pesticide/pdfs/122805_Imidacloprid.pdf
99. US-EPA (United States Environmental Protection Agency), 2012. Acetamiprid; Pesticide Tolerances. EPA-HQ-OPP-2011-0403; FRL-9340-7 Federal Register 2012: 77 (60): 18710-18716. Available online: www.gpo.gov/fdsys/pkg/FR-2012-03-28/html/2012-7461.htm
100. Watanabe M, Inoue Y, Sakimura K and Mishina M, 1992. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport, 3, 1138–1140.
101. Webster R, 2009. Blood brain barrier maturation: implications for drug development. Available online: www.ema.europa.eu/docs/en_GB/document_library/Presentation/2009/11/WC500009793.pdf
102. WHO (World Health Organization), 2001. Joint Meeting on Pesticide Residues. Toxicological evaluations: Imidacloprid. 28 pp. Available online: www.inchem.org/documents/jmpr/jmpmono/2001pr07.htm
103. WHO (World Health Organization), 2011. Joint FAO-WHO meeting on Pesticide residues in food - Evaluations 2011. Available online: apps.who.int/iris/bitstream/10665/75147/1/9789241665278_eng.pdf
104. Williams NM, Franke B, Mick E, Anney RJ, Freitag CM, Gill M, Thapar A, O'Donovan MC, Owen MJ, Holmans P, Kent L, Middleton F, Zhang-James Y, Liu L, Meyer J, Nguyen TT, Romanos J, Romanos M, Seitz C, Renner TJ, Walitza S, Warnke A, Palmason H, Buitelaar J, Rommelse N, Vasquez AA, Hawi Z, Langley K, Sergeant J, Steinhausen HC, Roeyers H, Biederman J, Zaharieva I, Hakonarson H, Elia J, Lionel AC, Crosbie J, Marshall CR, Schachar R, Scherer SW, Todorov A, Smalley SL, Loo S, Nelson S, Shtir C, Asherson P, Reif A, Lesch KP and Faraone SV, 2012. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry, 169, 195–204.
105. Wonnacott S, 1997. Presynaptic nicotinic ACh receptors. Trends Neurosci, 20, 92–98.
106. Wu CH, Lee CH and Ho YS, 2011. Nicotinic Acetylcholine Receptor-Based Blockade: Applications of Molecular Targets for Cancer Therapy. Clin Cancer Res, 17, 3533–3541.
107. Yan GM, Ni B, Weller M, Wood KA and Paul SM, 1994. Depolarisation or glutamate receptor activation blocks apoptotic cell death of cultured cerebellar granule neurons. Brain Res, 656, 43–51.
108. Yasui DH, Scoles HA, Horike S, Meguro-Horike M, Dunaway KW, Schroeder DI and Lasalle JM, 2011. 15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Hum Mol Genet, 20, 4311–4323.
109. Zhang X, Liu C, Miao H, Gong ZH and Nordberg A, 1998. Postnatal changes of nicotinic acetylcholine receptor alpha 2, alpha 3, alpha 4, alpha 7 and beta 2 subunits genes expression in rat brain Int J Dev Neurosci, 16, 507–518.